Skip to content

Teleflex TFX Free cash flow

Free cash flow at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$546M
Boston Scientific logo
Boston ScientificBSX
$171M-51.7%
Medtronic logo
MedtronicMDT
$2.09B+0.8%
Stryker logo
StrykerSYK
$415M+227%
Abbott logo
AbbottABT
$916M-1.8%
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$548.3M+32.3%
Gross profit$307.4M+20.4%
Operating income$20.2M-73.4%
Net income-$8.2M-109%
EPS (diluted)-$0.18-109%

Balance sheet

See full
Cash & equivalents$329.6M+16.8%
Total debt$2.8B+38.6%
Total equity$3.1B-24.7%
Total assets$6.8B-5.3%

Cash flow

See full
Operating cash flow$46.7M+68.3%
CapEx$18.8M-22.1%

Valuation

See full
Market cap$5.62B-14.4%
Enterprise value$8.07B-2.0%
P/S2.6×-1.2×

Profitability

See full
Gross margin38.2%-3.0pp
Operating margin3%-11.8pp
Net margin-47.4%-56.2pp
FCF margin7.9%

Returns & leverage

See full
Return on equity-28.1%-31.6pp
Debt / equity0.9×+0.4×
Current ratio2.6×+0.3×

Where this comes from

Calculated from Teleflex’s reported figures.

The official record: Teleflex’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Teleflex's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Teleflex's free cash flow?
Teleflex (TFX) reported free cash flow of $27.87M in Q1 2026.
How has Teleflex's free cash flow changed year-over-year?
Teleflex's free cash flow increased by 675.9% year-over-year, from $3.59M to $27.87M.
What is the long-term trend for Teleflex's free cash flow?
Over 3 years (2021 to 2024), Teleflex's free cash flow has grown at a -12.1% compound annual growth rate (CAGR), from $580.52M to $394.07M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.